Tanezumab Biosimilar, NGF Monoclonal Antibody

Additional Information:
C110P: Tanezumab Biosimilar, NGF Monoclonal AntibodyRecombinant Humanized IgG2 Monoclonal Antibody.|Isotype: Human IgG2 kap|The anti-human NGF monoclonal antibody tanezumab biosimilar was produced in mammal cells.|Specificity/Sensitivity: The in vivo grade tanezumab biosimilar specifically binds to the NGF protein.|Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological |0.2 uM filtered solution, pH 7.4, no stabilizers or preservatives.|Endotoxin: |Purity: >95% by SDS-|The research grade tanezumab biosimilar is shipped with ice |Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70°C as supplied.1 month from date of receipt, 2 to 8°C as supplied.|BackgroundWhat is tanezumab biosimilar research grade? Tanezumab is a humanized IgG2-kappa monoclonal antibody against nerve growth factor (NGF) as a treatment for pain v a novel mechanisms different from conventional pain-killer drugs. NGF levels increase in the body as a result of injury, inflammation or in chronic pain states. Tanezumab selectively targets, binds to, and inhibits NGF. Tanezumab acts in the periphery in a different manner than opioids and other analgesics, including nonsteroidal anti-inflammatory drugs (NSAIDs), and in studies to date, tanezumab has not demonstrated a risk of addiction, misuse or dependence. Tanezumab biosimilar uses the same protein sequences as the therapeutic antibody tanezumab.Syd Labs provides the following research grade antibody biosimilars used in ADCs:Tusamitamab biosimilar, research grade, anti-human CEACAM5 monoclonal antibodyRovalpituzumab biosimilar, research grade, anti-human DLL3 monoclonal antibodyTrastuzumab biosimilar, research grade, anti-human HER2 monoclonal antibodyCofetuzumab biosimilar, research grade, anti-human PTK7 monoclonal antibodyIfinatamab biosimilar, research grade, anti-human B7-H3 (CD276) monoclonal antibodySacituzumab biosimilar, research grade, anti-human Trop-2 monoclonal antibodyGemtuzumab biosimilar, research grade, anti-human CD33 monoclonal antibodyPolatuzumab biosimilar, research grade, anti-human CD79B monoclonal antibodyCetuximab biosimilar, research grade, anti-human EGFR monoclonal antibody